Part I -
Financial Information:
|
Page
No.
|
||
Item 1
–
|
Financial
Statements
|
||
Condensed
Consolidated Balance Sheets – September 30,
2008 and December 31, 2007
|
3
|
||
Condensed
Consolidated Statements of Operations –Nine and Three Months Ended
September 30, 2008 and 2007
|
4
|
||
Condensed
Consolidated Statements of Cash Flows –Nine Months Ended September 30,
2008 and 2007
|
5
|
||
Notes to
Condensed Consolidated Financial Statements
|
6
|
||
Item 2
-
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
18
|
|
Item 3
-
|
Quantitative
and Qualitative Disclosures About Market Risk
|
21
|
|
Item 4
–
|
Controls and
Procedures
|
22
|
|
Part II –
Other Information:
|
Item 1
-
|
Legal
Proceedings
|
23
|
||
Item 1A
-
|
Risk
Factors
|
23
|
||
Item
5
|
Other
Information
|
23
|
||
Item 6
-
|
Exhibits
|
23
|
||
Signatures
|
25
|
|||
Exhibit
Index
|
26
|
|||
Exhibits
|
||||
Exhibit
31.1
|
||||
Exhibit
31.2
|
||||
Exhibit
32.1
|
||||
Exhibit
32.2
|
||||
September
30,
|
December
31,
|
||||||
2008
|
2007
|
||||||
Assets
|
|||||||
Current
assets:
|
|||||||
Cash and cash
equivalents
|
$ | 26,615,134 | $ | 71,626,379 | |||
Short-term
marketable securities
|
53,837,495 | - | |||||
Receivables,
less allowance for
|
|||||||
doubtful
accounts of $152,382 in
|
|||||||
2008
and $285,223 in 2007
|
70,732,120 | 59,932,808 | |||||
Inventories
|
67,661,975 | 69,228,312 | |||||
Insurance
receivable – asbestos
|
11,000,000 | 10,000,000 | |||||
Other current
assets
|
15,053,627 | 17,263,397 | |||||
Total current
assets
|
244,900,351 | 228,050,896 | |||||
Property,
plant and equipment, net
|
84,956,855 | 75,101,225 | |||||
Insurance
receivable - asbestos
|
74,971,154 | 84,547,965 | |||||
Investment in
joint ventures
|
6,690,848 | 4,206,149 | |||||
Deferred tax
assets
|
- | 2,195,953 | |||||
Prepaid
pensions
|
2,262,903 | 1,701,839 | |||||
Goodwill
|
2,694,240 | 2,694,240 | |||||
Other
noncurrent assets
|
5,940,590 | 5,893,877 | |||||
$ | 422,416,941 | $ | 404,392,144 | ||||
Liabilities
and Shareholders' Equity
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable
|
$ | 21,682,866 | $ | 19,418,106 | |||
Accrued
payrolls and employee benefits
|
12,838,350 | 12,968,395 | |||||
Industrial
Revenue Bond debt
|
13,311,000 | 13,311,000 | |||||
Asbestos
liability – current portion
|
17,000,000 | 20,000,000 | |||||
Other current
liabilities
|
28,994,806 | 25,448,981 | |||||
Total current
liabilities
|
93,827,022 | 91,146,482 | |||||
Employee
benefit obligations
|
18,125,432 | 19,721,794 | |||||
Asbestos
liability
|
90,978,431 | 99,722,526 | |||||
Deferred tax
liabilities
|
1,573,425 | - | |||||
Other
noncurrent liabilities
|
3,184,248 | 6,070,852 | |||||
Total
liabilities
|
207,688,558 | 216,661,654 | |||||
Commitments
and contingent liabilities
|
|||||||
(Note
6)
|
|||||||
Shareholders'
equity:
|
|||||||
Preference
stock - no par value;
|
|||||||
authorized
3,000,000 shares; none issued
|
- | - | |||||
Common stock
- par value $1; authorized
|
|||||||
20,000,000
shares; issued and outstanding
|
|||||||
10,177,497
shares in 2008 and 2007
|
10,177,497 | 10,177,497 | |||||
Additional
paid-in capital
|
113,176,296 | 111,897,093 | |||||
Retained
earnings
|
119,462,981 | 91,232,890 | |||||
Accumulated
other comprehensive loss
|
(28,088,391 | (25,576,990 | ) | ||||
Total
shareholders' equity
|
214,728,383 | 187,730,490 | |||||
$ | 422,416,941 | $ | 404,392,144 | ||||
Nine Months
Ended September 30,
|
Three Months
Ended September 30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Net
sales
|
$ | 306,425,474 | $ | 263,640,134 | $ | 105,906,219 | $ | 87,159,691 | ||||||||
Operating
costs and expenses:
|
||||||||||||||||
Costs
of products sold
|
||||||||||||||||
(excluding
depreciation)
|
218,592,931 | 185,257,745 | 76,160,867 | 61,309,784 | ||||||||||||
Selling
and administrative
|
32,364,008 | 29,843,338 | 11,432,512 | 10,063,857 | ||||||||||||
Depreciation
|
5,427,038 | 5,097,501 | 1,758,635 | 1,580,417 | ||||||||||||
Gain on
disposition of assets
|
(92,559 | ) | (33,342 | ) | (8,291 | ) | (348 | ) | ||||||||
Total
operating expenses
|
256,291,418 | 220,165,242 | 89,343,723 | 72,953,710 | ||||||||||||
Income from
operations
|
50,134,056 | 43,474,892 | 16,562,496 | 14,205,981 | ||||||||||||
Other income
(expense):
|
||||||||||||||||
Investment-related
income
|
1,419,350 | 1,215,920 | 224,309 | 257,675 | ||||||||||||
Interest
expense
|
(369,770 | ) | (551,462 | ) | (121,911 | ) | (190,024 | ) | ||||||||
Other –
net
|
(429,697 | ) | (993,434 | ) | 765,754 | (348,002 | ) | |||||||||
619,883 | (328,976 | ) | 868,152 | (280,351 | ) | |||||||||||
Income before
income taxes
|
50,753,939 | 43,145,916 | 17,430,648 | 13,925,630 | ||||||||||||
Income tax
provision
|
17,028,000 | 14,105,000 | 5,457,000 | 4,527,000 | ||||||||||||
Net
income
|
$ | 33,725,939 | $ | 29,040,916 | $ | 11,973,648 | $ | 9,398,630 | ||||||||
Net income
per common share:
|
||||||||||||||||
Basic
|
$ | 3.31 | $ | 2.90 | $ | 1.18 | $ | 0.92 | ||||||||
Diluted
|
$ | 3.31 | $ | 2.88 | $ | 1.18 | $ | 0.92 | ||||||||
Cash
dividends declared
|
||||||||||||||||
per
share
|
$ | 0.54 | $ | 0.45 | $ | 0.18 | $ | 0.15 | ||||||||
Weighted
average number of
|
||||||||||||||||
common
shares outstanding:
|
||||||||||||||||
Basic
|
10,177,497 | 10,002,292 | 10,177,497 | 10,177,497 | ||||||||||||
Diluted
|
10,179,769 | 10,084,271 | 10,179,735 | 10,179,788 |
Nine
Months
Ended
September 30,
|
||||||||
2008
|
2007
|
|||||||
Net cash
flows provided by operating activities
|
$ | 34,403,823 | $ | 28,356,849 | ||||
Cash flows
from investing activities:
|
||||||||
Purchases of
property, plant and equipment
|
(16,703,433 | ) | (6,400,030 | ) | ||||
Purchases of
short-term marketable securities
|
(68,168,522 | ) | (54,006,962 | ) | ||||
Sales of
short-term marketable securities
|
15,000,000 | - | ||||||
Investment in
Chinese joint venture
|
(2,940,000 | ) | - | |||||
Purchases of
long-term marketable securities
|
(785,209 | ) | (1,805,618 | ) | ||||
Sales of
long-term marketable securities
|
667,325 | 1,722,500 | ||||||
Other
|
106,632 | (156,582 | ) | |||||
Net cash
flows used in investing activities
|
(72,823,207 | ) | (60,646,692 | ) | ||||
Cash flows
from financing activities:
|
||||||||
Dividends
paid
|
(5,190,524 | ) | (3,987,124 | ) | ||||
Proceeds from
the issuance of common stock
|
- | 3,625,809 | ||||||
Excess tax
benefits from the exercise of stock
|
||||||||
options
|
- | 429,660 | ||||||
Net cash
flows (used in) provided by
|
||||||||
financing
activities
|
(5,190,524 | ) | 68,345 | |||||
Effect of
exchange rate changes on cash
|
||||||||
and cash
equivalents
|
(1,401,337 | ) | 294,619 | |||||
Net decrease
in cash and cash equivalents
|
(45,011,245 | ) | (31,926,879 | ) | ||||
Cash and cash
equivalents at beginning of period
|
71,626,379 | 56,083,870 | ||||||
Cash and cash
equivalents at end of period
|
$ | 26,615,134 | $ | 24,156,991 | ||||
Supplemental
information:
|
||||||||
Income
tax payments
|
$ | 9,978,896 | $ | 9,535,693 | ||||
Interest
payments
|
$ | 373,221 | $ | 556,052 | ||||
Non-cash
investing activities:
|
||||||||
Appreciation
of short-term marketable
|
||||||||
securities
|
$ | 668,973 | $ | 1,519,002 | ||||
Purchases
of property, plant and equipment
|
||||||||
included
in accounts payable
|
$ | 1,377,432 | $ | - | ||||
1.
|
Unaudited Condensed
Consolidated Financial
Statements
|
2.
|
Inventories
|
(in
thousands)
|
|||||||
September
30,
|
December
31,
|
||||||
2008
|
2007
|
||||||
Raw
materials
|
$ | 14,150 | $ | 14,197 | |||
Work-in-process
|
34,911 | 35,924 | |||||
Finished
goods
|
9,078 | 10,486 | |||||
Supplies
|
9,523 | 8,621 | |||||
$ | 67,662 | $ | 69,228 |
|
Property,
plant and equipment were comprised of the
following:
|
(in
thousands)
|
|||||||
September
30,
|
December
31,
|
||||||
2008
|
2007
|
||||||
Land and land
improvements
|
$ | 4,728 | $ | 4,507 | |||
Buildings
|
30,862 | 27,371 | |||||
Machinery and
equipment
|
145,547 | 142,258 | |||||
Construction-in-progress
|
13,820 | 6,459 | |||||
Other
|
7,379 | 7,074 | |||||
202,336 | 187,669 | ||||||
Accumulated
depreciation
|
(117,379 | ) | (112,568 | ) | |||
$ | 84,957 | $ | 75,101 |
4.
|
Other Current Liabilities
|
(in
thousands)
|
|||||||
September
30,
|
December
31,
|
||||||
2008
|
2007
|
||||||
Customer-related
liabilities
|
$ | 8,234 | $ | 9,248 | |||
Accrued
income taxes
|
4,244 | 819 | |||||
Foreign
exchange contracts
|
4,044 | 4,832 | |||||
Accrued sales
commissions
|
3,762 | 3,161 | |||||
Other
|
8,711 | 7,389 | |||||
$ | 28,995 | $ | 25,449 |
(in
thousands)
|
||||||||||||||||
Nine
Months
|
Three
Months
|
|||||||||||||||
Ended
September 30,
|
Ended
September 30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Balance at
beginning of the period
|
$ | 6,156 | $ | 5,567 | $ | 5,768 | $ | 6,779 | ||||||||
Satisfaction
of warranty claims
|
(3,150 | ) | (2,115 | ) | (1,195 | ) | (870 | ) | ||||||||
Provision for
warranty claims
|
2,490 | 2,913 | 919 | 548 | ||||||||||||
Other,
primarily impact from
|
||||||||||||||||
changes
in foreign currency
|
||||||||||||||||
exchange
rates
|
(333 | ) | 147 | (329 | ) | 55 | ||||||||||
Balance at
end of the period
|
$ | 5,163 | $ | 6,512 | $ | 5,163 | $ | 6,512 |
(in
thousands)
|
||||||||
2008
|
2007
|
|||||||
U.S. pension
defined benefits plans
|
$ | - | $ | - | ||||
U.K. pension
defined benefits plan
|
$ | 1,352 | $ | 1,326 | ||||
Other
postretirement benefits
(e.g. net
payments)
|
$ | 439 | $ | 499 | ||||
U.K. defined
contribution plan
|
$ | 382 | $ | 362 | ||||
(in
thousands)
|
||||||||||||||||
U.S. Pension
Benefits
|
||||||||||||||||
Nine
Months
|
Three
Months
|
|||||||||||||||
Ended
September 30,
|
Ended
September 30,
|
|||||||||||||||
2008
|
2007
|
2008 2007
|
|
|||||||||||||
Service
cost
|
$ | 1,978 | $ | 1,980 | $ | 634 | $ | 641 | ||||||||
Interest
cost
|
5,949 | 5,755 | 1,989 | 1,971 | ||||||||||||
Expected
return on plan assets
|
(8,403 | ) | (8,723 | ) | (2,798 | ) | (2,901 | ) | ||||||||
Amortization
of:
|
||||||||||||||||
Prior
service cost
|
488 | 481 | 164 | 161 | ||||||||||||
Actuarial
gain
|
(98 | ) | (86 | ) | (33 | ) | (18 | ) | ||||||||
Net benefit
income
|
$ | (86 | ) | $ | (593 | ) | $ | (44 | ) | $ | (146 | ) |
(in
thousands)
|
||||||||||||||||
U.K. Pension
Benefits
|
||||||||||||||||
Nine
Months
|
Three
Months
|
|||||||||||||||
Ended
September 30,
|
Ended
September 30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Interest
cost
|
$ | 1,944 | $ | 2,023 | $ | 624 | $ | 685 | ||||||||
Expected
return on plan assets
|
(2,061 | ) | (1,990 | ) | (661 | ) | (674 | ) | ||||||||
Amortization
of actuarial loss
|
230 | 351 | 73 | 119 | ||||||||||||
Net benefit
cost
|
$ | 113 | $ | 384 | $ | 36 | $ | 130 |
(in
thousands)
|
||||||||||||||||
Other
Postretirement Benefits
|
||||||||||||||||
Nine
Months
|
Three
Months
|
|||||||||||||||
Ended
September 30,
|
Ended
September 30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Service
cost
|
$ | 304 | $ | 300 | $ | 101 | $ | 103 | ||||||||
Interest
cost
|
589 | 568 | 196 | 151 | ||||||||||||
Amortization
of:
|
||||||||||||||||
Prior
service cost
|
51 | 26 | 17 | 8 | ||||||||||||
Actuarial
loss (gain)
|
42 | 76 | 14 | (1 | ) | |||||||||||
Net benefit
cost
|
$ | 986 | $ | 970 | $ | 328 | $ | 261 |
6.
|
Commitments and
Contingent Liabilities
|
(in
thousands)
|
||||||||||||||||
Nine
Months
|
Three
Months
|
|||||||||||||||
Ended
September 30,
|
Ended
September 30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Net
income
|
$ | 33,726 | $ | 29,041 | $ | 11,974 | $ | 9,399 | ||||||||
Foreign
currency translation
|
||||||||||||||||
adjustments
|
(5,143 | ) | 672 | (5,398 | ) | (508 | ) | |||||||||
Unrecognized
components of
|
||||||||||||||||
employee
benefit plans
|
452 | 566 | 140 | 188 | ||||||||||||
Unrealized
holding gains
|
||||||||||||||||
(losses)
on marketable securities
|
209 | 1,020 | (63 | ) | 358 | |||||||||||
Change in the
fair value
|
||||||||||||||||
of
derivatives (cash flow hedges)
|
1,971 | (1,108 | ) | 2,605 | (791 | ) | ||||||||||
Comprehensive
income
|
$ | 31,215 | $ | 30,191 | $ | 9,258 | $ | 8,646 |
(in
thousands)
|
||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
Investments
|
||||||||||||||||
Short-term
marketable securities
|
$ | - | $ | 53,837 | $ | - | $ | 53,837 | ||||||||
Other
noncurrent assets
|
2,566 | - | - | 2,566 | ||||||||||||
Foreign
currency contracts
|
||||||||||||||||
Other current
assets
|
- | 2,280 | - | 2,280 | ||||||||||||
Other
noncurrent assets
|
- | 1,071 | - | 1,071 | ||||||||||||
Other current
liabilities
|
- | 4,044 | - | 4,044 | ||||||||||||
Other
noncurrent liabilities
|
- | 989 | - | 989 |
(in
thousands)
|
||||||||||||||||
Nine
Months
|
Three
Months
|
|||||||||||||||
Ended
September 30,
|
Ended
September 30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Net
Sales:
|
||||||||||||||||
Forged
and Cast Rolls
|
$ | 223,053 | $ | 185,010 | $ | 80,059 | $ | 61,251 | ||||||||
Air and
Liquid Processing
|
83,372 | 78,630 | 25,847 | 25,909 | ||||||||||||
Total
Reportable Segments
|
$ | 306,425 | $ | 263,640 | $ | 105,906 | $ | 87,160 | ||||||||
Income before
income taxes:
|
||||||||||||||||
Forged
and Cast Rolls
|
$ | 49,426 | $ | 41,345 | $ | 17,834 | $ | 13,222 | ||||||||
Air and
Liquid Processing
|
7,286 | 6,925 | 1,910 | 2,629 | ||||||||||||
Total
Reportable Segments
|
56,712 | 48,270 | 19,744 | 15,851 | ||||||||||||
Other
expense, including
|
||||||||||||||||
corporate
costs – net
|
(5,958 | ) | (5,124 | ) | (2,313 | ) | (1,925 | ) | ||||||||
Total
|
$ | 50,754 | $ | 43,146 | $ | 17,431 | $ | 13,926 | ||||||||
Approximate
open claims at end of period
|
9,372
|
(1)
|
Gross
settlement and defense costs (in 000’s)
|
$12,659
|
|
Approximate
claims settled or dismissed
|
728
|
|
|
(1) Included
as “open claims” are approximately 3,255 claims classified in various
jurisdictions as “inactive” or transferred to a state or federal judicial
panel on multi-district litigation, commonly referred to as the
MDL.
|
·
|
HR&A’s
interpretation of a widely accepted forecast of the population likely to
have been exposed to asbestos;
|
·
|
epidemiological
studies estimating the number of people likely to develop asbestos-related
diseases;
|
·
|
HR&A’s
analysis of the number of people likely to file an asbestos-related injury
claim against the subsidiaries and the Corporation based on such
epidemiological data and relevant claims history from January 1, 2004
through August 31, 2006;
|
·
|
an analysis
of pending cases, by type of injury claimed and jurisdiction where the
claim is filed;
|
·
|
an analysis
of claims resolution history from January 1, 2004 through August 31, 2006
to determine the average settlement value of claims, by type of injury
claimed and jurisdiction of filing;
and
|
·
|
an adjustment
for inflation in the future average settlement value of claims, at an
annual inflation rate based on the Congressional Budget Office’s ten year
forecast of inflation.
|
ITEM 2 - MANAGEMENT'S
DISCUSSION AND ANALYSIS OF
|
FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
|
·
|
Investment-related
income increased for the nine months ended September 30, 2008 primarily
due to receipt of a larger dividend from the Corporation’s Chinese
cast-roll joint venture in each of the second quarters. The
dividend approximated $800,000 in 2008 versus $540,000 in 2007. The
reduction in investment-related income for the three months ended
September 30, 2008 is attributable to the general decline in interest
rates.
|
·
|
Interest
expense decreased for each of the periods due to lower average interest
rates incurred on the outstanding Industrial Revenue
Bonds.
|
·
|
Other-net
includes approximately $960,000 of income resulting the reduction in the
accrual for environmental remediation of a previously sold location offset
by higher foreign exchange losses in 2008 when compared to
2007.
|
ITEM 3 – QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
|
ITEM 4 – CONTROLS AND
PROCEDURES
|
- 22
-
|
|
PART II - OTHER
INFORMATION
|
|
(a)
|
Articles of
Incorporation
|
|
(b)
|
By-laws
|
|
(a)
|
2008 Omnibus
Incentive Plan
|
(31.1)
|
Certification
of the principal executive officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
(31.2)
|
Certification
of the principal financial officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
(32.1)
|
Certification
of principal executive officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
|
(32.2)
|
Certification
of principal financial officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
|
AMPCO-PITTSBURGH
CORPORATION
|
|
DATE: November 7,
2008
|
BY: s/Robert A.
Paul
|
Robert A.
Paul
|
|
Chairman
and
|
|
Chief
Executive Officer
|
|
DATE: November 7,
2008
|
BY: s/Marliss D.
Johnson
|
Marliss D.
Johnson
|
|
Vice
President
|
|
Controller
and Treasurer
|
|
Exhibit
|
(31.1)
|
Certification
of principal executive officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
(31.2)
|
Certification
of principal financial officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|
Exhibit
|
(32.1)
|
Certification
of principal executive officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
|
(32.2)
|
Certification
of principal financial officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
|
|